Shopping Cart
- Remove All
- Your shopping cart is currently empty
Afizagabar (S44819) is a first-in-class, competitive, and selective antagonist at the GABA-binding site of the α5-GABAAR, with an IC50 of 585 nM for α5β2γ2 and a Ki of 66 nM for α5β3γ2. It enhances hippocampal synaptic plasticity and exhibits pro-cognitive efficacy [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,900 | 8-10 weeks | |
50 mg | $2,480 | 8-10 weeks | |
100 mg | $3,400 | 8-10 weeks |
Description | Afizagabar (S44819) is a first-in-class, competitive, and selective antagonist at the GABA-binding site of the α5-GABAAR, with an IC50 of 585 nM for α5β2γ2 and a Ki of 66 nM for α5β3γ2. It enhances hippocampal synaptic plasticity and exhibits pro-cognitive efficacy [1]. |
In vitro | Afizagabar (S44819) is a competitive α5-GABAAR antagonist (Kb=221 nM) that selectively inhibits extrasynaptic α5-GABAARs in mouse CA1 pyramidal neurons[1]. |
In vivo | Afizagabar (1 and 3 mg/kg; i.p.) significantly reduces the increase in total errors induced by Scopolamine[1]. |
Molecular Weight | 365.38 |
Formula | C19H12FN3O2S |
Cas No. | 1398496-82-6 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||
Solubility Information | DMSO: 6.25 mg/mL (17.11 mM), Sonication is recommended. | ||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.